I never said it was price sensitive or otherwise.. It is business and likely price positive.
Two professionals with influence in exactly the place OCC needs to facilitate clinical take up and accordingly commercial uses of Remplir in the US.
You guys are arguing minutia, rather than focusing on the positives.
- Forums
- ASX - By Stock
- Ann: Leading US-based nerve surgeons appointed to advisory board
I never said it was price sensitive or otherwise.. It is...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.54M |
Open | High | Low | Value | Volume |
37.0¢ | 37.0¢ | 36.5¢ | $8.036K | 21.85K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 120364 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 2520 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 120364 | 0.365 |
12 | 153390 | 0.360 |
5 | 47268 | 0.355 |
7 | 102739 | 0.350 |
2 | 31889 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 2520 | 1 |
0.375 | 13866 | 2 |
0.380 | 19190 | 2 |
0.385 | 45000 | 1 |
0.390 | 21421 | 4 |
Last trade - 10.33am 20/08/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |